Depression and anxiety in patients with head and neck cancer undergoing free flap reconstruction.

Autor: Pichardo PFA; Department of Otolaryngology - Head and Neck Surgery, Geisinger Medical Center, Danville, PA, United States of America., Desiato VM; Department of Otolaryngology - Head and Neck Surgery, Geisinger Medical Center, Danville, PA, United States of America., Hellums RN; Department of Otolaryngology - Head and Neck Surgery, Geisinger Medical Center, Danville, PA, United States of America., Altman KW; Department of Otolaryngology - Head and Neck Surgery, Geisinger Medical Center, Danville, PA, United States of America., Purdy NC; Department of Otolaryngology - Head and Neck Surgery, Geisinger Medical Center, Danville, PA, United States of America., Haugen T; Department of Otolaryngology - Head and Neck Surgery, Geisinger Medical Center, Danville, PA, United States of America. Electronic address: thaugen@geisinger.edu.
Jazyk: angličtina
Zdroj: American journal of otolaryngology [Am J Otolaryngol] 2024 Jan-Feb; Vol. 45 (1), pp. 104044. Date of Electronic Publication: 2023 Sep 12.
DOI: 10.1016/j.amjoto.2023.104044
Abstrakt: Purpose: To determine the prevalence and severity of depression and anxiety in patients with head and neck cancer (HNC) undergoing treatment with free-flap (FF) reconstruction.
Methods: Participants with HNC undergoing FF reconstruction were given the validated 9-item Patient Health Questionnaire (PHQ-9) and a 7-item Generalized Anxiety Disorder (GAD-7) questionnaire prior to surgery. Patient factors and responses were analyzed.
Results: Seventy-one patients were included. Mean (SD) pre-operative PHQ-9 was 7.6 (7.04) with 34 % (n = 24) having moderate to severe depression. Mean (SD) pre-operative GAD-7 was 6.5 (6.86) with 30 % (n = 21) having moderate to severe anxiety.
Conclusion: Prevalence of depression and anxiety is high in this cohort and undiagnosed in 22 % and 18 % of patients, respectively. Due to the findings, it is prudent to screen HNC patients at initial diagnosis and offer mental health services.
Competing Interests: Declaration of competing interest KWA: Merck (Consultant, Speaker, Publication Advisory Board (uncompensated)), Vindico (CME faculty in programs sponsored by Merck), AXDEV (Marketing consultant in a program sponsored by Merck), Bayer (Confidentiality Agreement, uncompensated). No other conflicts of interest to report.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: